Spectralytics, Inc. v. Cordis Corp. (II)

BVLaw
Full Text of Court Cases
June 13, 2011

Access the Full Article

This article and its downloads are available with a subscription to any of these products:
It is also available in this product:
Already a subscriber or product owner?  Login
This article is also available for purchase. (6,307 words)   Add to Cart >>
Need help? Contact us:
1-503-479-8200 ext 2 or sales@bvresources.com
3841 Surgical and Medical Instruments and Apparatus
339112 Surgical and Medical Instrument Manufacturing
intellectual property
Spectralytics, Inc. v. Cordis Corp. (II)
2011 WL 2307402 (C.A. Fed. (Mass.))
US
Federal Court
Federal Circuit
United States Court of Appeals
Julie Davis
Newman

Summary

Federal Circuit court affirms 5% royalty rate damages for infringement of patented medical device, based on expert evidence that showed a 20% rate would have been reasonable in light of economic and competitive circumstances.
Spectralytics, Inc. v. Cordis Corp. (II)
PDF, Size: 137 KB

See Also

Is a $22.5 Million Patent Award Reasonable When Plaintiff Sold for Only $4 Million?

Legal and Court Case Update
September 2011

Federal Circuit court affirms 5% royalty rate damages for infringement of patented medical device, based on expert evidence that showed a 20% rate would have been reasonable in light of economic and competitive circumstances.

This article also appears in:
Intellectual Property Valuation Case Law Compendium, Fourth Edition